SAN ANTONIO — Access to GLP-1 medications is potentially impacted by care site, payer type and demographics, highlighting gaps in care that disproportionately affect certain patient subgroups, according to a presentation at ObesityWeek.“We know that individuals that have obesity, but not diabetes, are a unique subpopulation in the context of metabolic health, because they may be
The Endocrine Society works to reduce the prevalence of obesity, identify policy options to address obesity, and advocate for access to affordable care.
We are excited to announce that the ERP DSMES Symposium and the Medicare Reimbursement symposium are now available on-demand until December 31, 2024. Both symposiums…
LOS ANGELES —In this video from IDWeek, Vani Vannappagari, MBBS, PhD, MPH, global head of epidemiology and real-world evidence at ViiV Healthcare, discusses study findings…
SAN ANTONIO — Access to GLP-1 medications is potentially impacted by care site, payer type and demographics, highlighting gaps in care that disproportionately affect certain…
PHILADELPHIA — Bezlotoxumab in combination with fecal microbiota transplantation did not further reduce recurrence of Clostridioides difficile infection in patients with inflammatory bowel disease, according…
SAN ANTONIO — Half of adolescents had two or more micronutrient deficiencies 10 years after metabolic and bariatric surgery, with deficiencies more common after Roux-en-Y…
The Best of ObesityWeek® | Your selection of highlights and key takeaways from ObesityWeek®.
Time-restricted eating can improve the health of individuals with metabolic syndrome, who are on the precipice of type 2 diabetes, heart disease and other health…
The Best of ObesityWeek® | Your selection of highlights and key takeaways from ObesityWeek®.
